JBT Marel Q1 revenue beats estimates on protein solutions growth
JBT Marel Corporation JBTM | 0.00 |
Overview
US food technology provider's Q1 revenue rose 10% yr/yr, beating analyst expectations
Adjusted EPS for Q1 beat consensus
Company reiterated full-year 2026 guidance for revenue growth and margin expansion
Outlook
JBT Marel reiterates FY 2026 revenue guidance of $3.99 bln to $4.065 bln
Company expects FY 2026 adjusted EPS of $8.00 to $8.50
JBT Marel anticipates FY 2026 adjusted EBITDA margin of 17.0% to 17.5%
Result Drivers
PROTEIN SOLUTIONS GROWTH - Revenue in Protein Solutions rose 22%, aided by higher poultry volume and improvements in meat and fish businesses
FOREIGN EXCHANGE IMPACT - Revenue growth included a 6% benefit from foreign exchange translation
MARGIN PRESSURE IN PREPARED FOOD & BEVERAGE - Flat revenue and lower margins in Prepared Food and Beverage Solutions due to higher tariffs, lower CPG volume, and warehouse automation challenges
Company press release: ID:nBw5S8V4ma
Key Details
Metric |
Beat/Miss |
Actual |
Consensus Estimate |
Q1 Revenue |
Beat |
$936 mln |
$924.85 mln (5 Analysts) |
Q1 Adjusted EPS |
Beat |
$1.58 |
$1.48 (5 Analysts) |
Q1 EPS |
|
$0.86 |
|
Q1 Net Income |
|
$45 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", no "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the industrial machinery & equipment peer group is "buy"
Wall Street's median 12-month price target for JBT Marel Corp is $190.00, about 64.6% above its May 1 closing price of $115.44
The stock recently traded at 14 times the next 12-month earnings vs. a P/E of 20 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
